Leaflet EVARTAN 5mg film-coated tablets


Indicated for: hypertension

Route of administration: oral

Substance: tertatolol (antihypertensive)

ATC: C07AA16 (Cardiovascular system | Beta blocking agents | Beta blocking agents, non-selective)

Tertatolol is a beta-blocker used for the treatment of hypertension and angina pectoris. It works by blocking beta-adrenergic receptors, thereby reducing heart rate and blood pressure.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not abruptly discontinue treatment, as this may worsen symptoms.

Patients should be aware of potential side effects, such as fatigue, dizziness, or bradycardia. It is important to inform the doctor of any unusual symptoms or the use of other medications.

Common side effects include fatigue, dizziness, bradycardia, and gastrointestinal disturbances. In rare cases, severe reactions such as heart failure or bronchospasm may occur. Patients should be informed of these risks before starting treatment.

General data about EVARTAN 5mg

  • Substance: tertatolol
  • Date of last drug list: 01-07-2013
  • Commercial code: W05824001
  • Concentration: 5mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 30
  • Product type: original
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.